• Stanford's Blood Flow Biosensor Heads to Human Trials

    Clinical Research News | After 15 years of development, Stanford University's Tom Soh is preparing to take his biosensor technology from laboratory rats to human volunteers. The device, which can continuously monitor molecules in flowing blood for up to seven days, represents a potential paradigm shift in clinical medicine.

    Jul 2, 2025

  • Walgreens ‘Built the Vessel’ for Making Clinical Trials a Care Option

    Clinical Research News | In the span of three years, Walgreens—an integral part of communities across the U.S. for well over a century—has positioned itself as a key player in the clinical trial ecosystem highlighted by more than 35 biopharma partnerships and the engagement of over 17 million customers participating in industry-sponsored studies. The thesis that co-locating trials where patients are “actually works."

    Jul 1, 2025

  • Follow the Money: Migraine Therapy, Reducing Trial Failure, More

    Clinical Research News | Salvia plans to further develop MySalvia Therapy in a multi-center, double-blind, sham-controlled study for people with chronic migraine; Vivodyne plans to scale its robotics+AI approach to testing on thousands of lab-grown, fully-functional human tissues, which aim to reduce human clinical trial failure; and more.

    Jun 25, 2025

  • Veeva, Sarah Cannon Research Institute Collaboration, City of Hope Receives Grant, More

    Clinical Research News | Veeva and Sarah Cannon Research Institute has entered a strategic collaboration; City of Hope was awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the US Department of Health and Human Services; and more.

    Jun 24, 2025

  • Beyond Vitals: How Patient-Generated Data is Driving AI’s Healthcare Transformation

    Clinical Research News | In recent years, AI in healthcare has attracted growing interest and investment, with new roles like Chief AI Officer and AI-specific policies underscoring its transformative potential. However, one critical factor is often overlooked: the quality of the data used to train AI algorithms. While AI’s impact is undeniable, its effectiveness depends on the depth, diversity, and granularity of the data it processes.

    Jun 20, 2025

  • Genetic Testing Transforms Medication Prescribing for Better Patient Outcomes

    Clinical Research News | The UK National Health Service’s PROGRESS trial has achieved remarkable clinical success, with one in four patients having their prescriptions adjusted based on genetic test results, leading to safer and more effective treatments. The PROGRESS trial’s interim results reveal that 95% of the 500 patients tested carried genetic variants that directly influence how they metabolize common medications.

    Jun 18, 2025